Project Details
Description
Narrative
Deep vein thrombosis (DVT) and the associated disease is one of the leading cause of mortality
and morbidity – yet technologies for fast and safe treatment of acute thrombosis are critically
lacking. The goal of this project is to enable new and effective treatment using forward viewing
catheter-delivered microbubble enhanced sonothrombolysis (FV-CAMUS) combined with novel
lysis enhancing agents. This new technology provides an innovative approach to improve the
efficiency and safety of intravascular thrombolysis.
Deep vein thrombosis (DVT) and the associated disease is one of the leading cause of mortality
and morbidity – yet technologies for fast and safe treatment of acute thrombosis are critically
lacking. The goal of this project is to enable new and effective treatment using forward viewing
catheter-delivered microbubble enhanced sonothrombolysis (FV-CAMUS) combined with novel
lysis enhancing agents. This new technology provides an innovative approach to improve the
efficiency and safety of intravascular thrombolysis.
| Status | Finished |
|---|---|
| Effective start/end date | 15/8/18 → 30/6/22 |
| Links | https://projectreporter.nih.gov/project_info_details.cfm?aid=10219344 |
Funding
- National Heart, Lung, and Blood Institute: US$522,382.00
- National Heart, Lung, and Blood Institute: US$615,747.00
- National Heart, Lung, and Blood Institute: US$632,171.00
ASJC Scopus Subject Areas
- Hematology
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.